CardioSignal provides a CE‑marked Class IIb medical device that turns a smartphone into a diagnostic tool for detecting atrial fibrillation. Using patented gyrocardiography, the app records heart motion via the phone’s built‑in sensors in a one‑minute, hands‑free measurement and delivers clinically validated results instantly, supporting self‑monitoring, remote care, and point‑of‑care screening.
Funding
$20.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MIFounders
Product
Problem
Detecting atrial fibrillation early is difficult because traditional ECG equipment is bulky, requires clinical visits, and many patients are asymptomatic, leading to missed diagnoses and increased risk of stroke and heart failure.
Solution
CardioSignal offers a CE‑marked Class IIb medical device that turns a standard smartphone into a diagnostic tool for atrial fibrillation detection. Using patented gyrocardiography, the app records heart motion via the phone’s accelerometer and gyroscope during a one‑minute, hands‑free measurement placed on the chest. Clinically validated studies report 96 % accuracy for identifying signs of atrial fibrillation. Results, including heart rate and a cardiogram, are displayed instantly in the app and stored in a secure cloud, enabling users to track trends, set measurement reminders, and share histories with healthcare providers. The solution supports self‑monitoring, remote patient care, and point‑of‑care screening in clinics, pharmacies, and hospitals, facilitating timely medical assessment and reducing complications.
Target Audience
Primary users are adults at risk for atrial fibrillation—including those with hypertension, diabetes, or advanced age—and healthcare providers such as primary‑care physicians, cardiologists, nurses, and pharmacists seeking scalable screening tools.
Features
- One‑minute, non‑invasive measurement using only the smartphone’s built‑in motion sensors
- Gyrocardiography algorithm validated in multiple clinical studies (≥96 % detection accuracy)
- CE Class IIb medical device compliance and ISO 13485/27001 certification
- Automatic heart‑rate calculation, measurement history, and customizable reminders
- In‑app insights and news feed to promote regular heart‑health monitoring
- Secure cloud storage with encrypted results and optional digital reporting for clinicians
- Compatibility with iOS and Android devices meeting sensor and OS requirements